Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 841 across all filing types
Latest filing 2025-08-26 Legal Proceedings Report
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Statement of Claim 1 page 123.4KB
Legal Proceedings Report Classification · 95% confidence The document is an ASX announcement dated 27 August 2025 regarding a legal action filed by Bioxyne Limited against a major shareholder, Mr Ian Edward Owles. It details the filing of a summons in the Supreme Court of New South Wales related to alleged misrepresentations and seeks relief under Australian Consumer Law. The content focuses on legal proceedings and does not contain financial statements, management discussion, or other report types. It is not a full audit report or annual report, nor is it a regulatory certification or voting result. The document is best classified as a Legal Proceedings Report (LTR) because it provides an update on a significant lawsuit involving the company.
2025-08-26 English
30 June 2025 Appendix 4C Revised 6 pages 318.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly cash flow report for entities subject to Listing Rule 4.7B' and contains detailed quarterly cash flow statements, including operating, investing, and financing activities, as well as reconciliation of cash and cash equivalents. It references the ASX Listing Rules and provides financial data for the quarter ended 30 June 2025. The document is approximately 12,071 characters long, which is substantial and contains actual financial data and analysis for a quarterly period. This matches the definition of an Interim / Quarterly Report (IR), which must contain substantive financial data and analysis for a period shorter than a full fiscal year. It is not merely an announcement or certification but a full quarterly cash flow report. Therefore, the correct classification is IR. Q4 2025
2025-08-17 English
Application for quotation of securities - BXN 7 pages 20.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement for the application for quotation of securities. It details the issuance and quotation of securities under an employee incentive scheme, including the number of securities, issue date, and other listing rule requirements. This type of document is specifically related to the announcement of new securities being quoted on the exchange, which corresponds to a Share Issue/Capital Change announcement. It is not a financial report, earnings release, or management discussion, but rather a formal notification of capital changes related to securities issuance and quotation.
2025-08-10 English
Cleansing Notice 1 page 184.9KB
Capital/Financing Update Classification · 95% confidence The document is a Cleansing Notice pursuant to Section 708A(5)(e) of the Corporations Act 2001, related to the issue of shares under an Employee Incentive Plan. It is an announcement about a share issue event and compliance with disclosure requirements, referencing an Appendix 2A. The document is short (1390 characters) and does not contain financial statements or detailed financial data. It is an announcement of a capital/financing activity (share issuance) rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP).
2025-08-10 English
Bioxyne Updated Investor Presentation 20 pages 2.2MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation focused on the company's quarterly financial performance, growth strategies, revenue figures, cash flow, and market outlook for Q4 FY25. It includes forward-looking statements, financial highlights, and operational updates. The presence of slides, disclaimers, and forward-looking guidance indicates this is a presentation prepared for investors or analysts. It is not a full annual or interim report, nor is it a transcript or regulatory filing. The content aligns with an Investor Presentation, which typically includes financials, strategy, and market position details in a summarized and visual format.
2025-07-28 English
Change of Shareholder Interest Notice 3 pages 149.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder, including dates and share quantities. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2025-07-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.